- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03995069
Novel Training Environment to Normalize Altered Finger Force Direction Post Stroke (NEAD)
Study Overview
Detailed Description
Despite the functional importance, fingertip forces are rarely explicitly addressed with feedback in therapy. This gap in treatment is due to a lack of tools to provide explicit feedback on patients' volitional finger force generation. To address this unmet need, the investigators developed a novel tool for practice of volitional three-dimensional (3D) force generation with explicit feedback. The objective of this project is to determine if 3D finger force training is an effective tool in restoring hand function post stroke.
Stroke survivors with moderate to severe hand impairment with at least palpable volitional grip force will randomly be assigned to either the experimental or control group, stratified by impairment level. Both groups will undergo 3 1-hr training sessions per week for 6 weeks in which they practice volitional finger force generation against force sensors. The experimental group will practice for various target force directions to explore the 3D force workspace and receive feedback in 3D force, while the control group will practice 1D force generation without feedback on other directional forces on a computer screen.
Training will progress by increasing influence of flexion synergy by varying posture requirements and increasing force level, introducing feedback delay, and incorporating unilateral/bilateral activity. Evaluation will occur at baseline (3 times over 3 weeks to establish baseline trends) and every 2 weeks during 6-week intervention to determine pattern of progress, and at 1-month follow-up to assess retention.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
South Carolina
-
Charleston, South Carolina, United States, 29401-5703
- Ralph H. Johnson VA Medical Center, Charleston, SC
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Survived a stroke at least 3 months ago
- Moderate to severe hand impairment (Chedoke-McMaster Hand Stage 2-4)
- Ability to generate palpable volitional grip force upon cue
- Sufficient cognitive ability to participate (NIH Stroke Scale, NIHSS, Questions and Commands score = 0-1)
- Ability to recognize all quadrants of the visual field (NIHSS Visual Field Test score = 0)
Exclusion Criteria:
- Concurrent upper limb rehabilitation
- Inability to follow 2-step commands
- Severe muscle tone prohibiting passive movement of the fingers or proper placement of the fingers on the force sensors as needed to participate in the training (Modified Ashworth Scale=4-5 out of 5)
- Change in spasticity medication or botulinum toxin injection in the upper limb within 3 months prior to or during enrollment
- Total sensory loss on fingertips (NIHSS Sensory score=2)
- Comorbidity (e.g., orthopaedic conditions that limit ranges of motion, premorbid neurologic conditions)
- Language barrier or cognitive impairment that precludes providing consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 3D
The participant's voluntary grip forces in all 3 dimensions will be shown to the participant via computer screen.
|
Practice generating grip force to the target shown on the computer screen in 3 dimensions.
|
|
Active Comparator: 1D
The participant's voluntary grip force in 1 dimension will be shown to the participant via computer screen.
|
Practice generating grip force to the target shown on the computer screen in 1 dimension.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Action Research Arm Test (ARAT)
Time Frame: baseline to within 1 week post intervention
|
change in a clinical assessment, ARAT, that is in a scale 0-57 with a higher score representing better upper extremity function
|
baseline to within 1 week post intervention
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Box and Block Test
Time Frame: baseline to within 1 week post intervention
|
a clinical assessment measuring the number of blocks that a person can move in a minute, with a higher score representing better upper extremity function
|
baseline to within 1 week post intervention
|
|
Box and Block Test
Time Frame: baseline to 1 month post intervention
|
a clinical assessment for upper extremity function.
|
baseline to 1 month post intervention
|
|
Stroke Impact Scale Hand Subscale
Time Frame: baseline to within 1 week post intervention
|
Perceived difficulty in using the affected hand for activities of daily living.
Scale 0-100.
A higher score represents better function (less difficulty).
|
baseline to within 1 week post intervention
|
|
Action Research Arm Test
Time Frame: baseline to 1 month post intervention
|
change in a clinical assessment of Action Research Arm Test that is in a scale 0-57 with a higher score representing better upper extremity function
|
baseline to 1 month post intervention
|
|
Stroke Impact Scale Hand Subscale
Time Frame: baseline to 1 month post intervention
|
Perceived difficulty in using the affected hand for activities of daily living.
Scale 0-100.
A higher score represents better function (less difficulty).
|
baseline to 1 month post intervention
|
Collaborators and Investigators
Investigators
- Principal Investigator: Na Jin Seo, PhD MS BS, Ralph H. Johnson VA Medical Center, Charleston, SC
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- A3066-R
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
Clinical Trials on 3D
-
Washington University School of MedicineAllerganCompletedHypomastia | Primary Breast AugmentationUnited States
-
Zhujiang HospitalUnknownLiver Diseases | Biliary Tract Diseases | Pancreatic DiseasesChina
-
Somogy Megyei Kaposi Mór Teaching HospitalEnrolling by invitationStroke | Multiple Sclerosis | PARKINSON DISEASE (Disorder)Hungary
-
Wuhan Union Hospital, ChinaNot yet recruiting
-
Rigshospitalet, DenmarkTechnical University of DenmarkCompleted
-
Universitätsklinikum Hamburg-EppendorfUnknown
-
University of PecsCompletedScoliosis Idiopathic | Scoliosis, SevereHungary
-
Martini-Klinik am UKE GmbHRecruitingProstate Cancer (Adenocarcinoma)Germany
-
Moataz Sleem Ahmed AliNot yet recruiting